分子和临床方面与辅导具有不确定潜力的克隆性血液形成的个体有关
Anna Maria Cacic1,2, Felicitas Isabel Schulz1,2, Ulrich Germing1,2
1Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine Universität Düsseldorf, Düsseldorf, Germany.
Frontiers in oncology
|January 1, 2024
概括
不确定潜力的克隆性血液形成 (CHIP) 涉及与癌症和心血管疾病相关的与年龄相关的血液细胞突变. 早期检测和咨询对于管理风险至关重要,尽管治疗方法仍在发展.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 心血管医学 心血管医学
背景情况:
- 不确定潜力的克隆性血液形成 (CHIP) 是一种最近发现的现象,涉及血液细胞中与年龄相关的体质突变.
- CHIP与血液恶性瘤的风险增加有关,例如骨髓质疏松综合征 (MDS) 和急性髓性白血病 (AML).
- CHIP还显著增加了心血管疾病的风险,包括心肌梗塞,中风,心力衰竭和肺高血压.
研究的目的:
- 描述CHIP的基本方面.
- 解释CHIP与血液恶性瘤和心血管疾病之间的关联.
- 探索CHIP患者临床管理方面的潜在进展.
主要方法:
- 检测血液中癌症相关基因中的克隆扩展体质突变.
- 对CHIP相关突变的分析,通常涉及DNA损伤修复基因.
- 审查证据,将CHIP与心血管病理生理学联系起来,包括突变克隆性巨细胞.
主要成果:
- CHIP的特点是癌症相关基因的体质突变,容易发生血液性瘤.
- CHIP显著增加了心血管事件和疾病的风险.
- CHIP的危险因素包括衰老,吸烟,慢性炎症,睡眠不足和高出生体重.
结论:
- CHIP将血液和心血管风险联系在一起,需要对患者进行仔细的咨询和管理.
- 为减轻健康风险,建议为CHIP患者提供专门的门诊诊所.
- 虽然治疗方法有限,但对于心血管风险管理和未来的基因功能恢复策略存在有希望的方法.
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
01:21Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
01:22Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
01:19Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K